Weekly Roundup6 min read

Weekly FDA Roundup: a "sterile" horse wound product is tied to at least 20 deaths, and FDA plans to replace its vape review rule, September 26–October 2, 2026

Fungus-contaminated HYCOAT is tied to nearly 100 horse joint infections and at least 20 deaths. Plus FDA's plan to rewrite the PMTA rule and 21 warning letters in one day.

Weekly FDA Roundup: a "sterile" horse wound product is tied to at least 20 deaths, and FDA plans to replace its vape review rule, September 26–October 2, 2026

A wound-care solution labeled sterile, packaged like an injectable, and commonly injected into horses' joints turned out to be contaminated with fungi. FDA says nearly 100 horses developed serious joint infections and at least 20 were euthanized, the most horse deaths ever tied to a quality defect in an FDA-regulated veterinary product. Warning letters to Neogen and Sciarra Aeromed led a batch of 21 letters posted September 29, in the same week FDA said it intends to replace its 2021 rule for reviewing e-cigarettes and nicotine pouches.

By the numbers

  • 57 FDA actions posted September 26 to October 2: 21 warning letters, 17 recalls, 10 Federal Register notices, 5 press releases, 1 guidance, 1 rule, 1 safety alert, and 1 import alert.
  • 21 warning letters, all posted September 29: 7 to drug and API manufacturers, 4 from FDA's Center for Veterinary Medicine (CVM), 3 for FSVP, 3 to food plants, and 4 others.
  • 13 CVM warning letters posted in the third quarter, the most in any quarter in our records since 2024.
  • 3 Class I recall entries: broccoli sprouts (Salmonella), Cabricharme cheese (undeclared egg), and bettergoods Lemon Alfredo Fettuccine (Listeria).
  • Standout: 13 illnesses in an E. coli O26:H11 outbreak linked to Graziers raw milk cheddar.

Lead story: fungus in a "sterile" vial, and nearly 100 injured horses

Neogen Vet HYCOAT is a hyaluronate sodium solution labeled as a sterile topical wound treatment for dogs, cats, and horses. It ships in a glass vial with a septum top, the same packaging as an injectable drug, and veterinarians commonly injected it into joints, an off-label use the label never warned against. Reports started reaching FDA in late 2025, and Neogen recalled all lots within expiry in late January.

The warning letter to Neogen, dated September 23, says FDA testing of lot 5A001 found viable contamination, including five fungal species. One of them, Purpureocillium lilacinum, is particularly resistant to antifungal drugs, according to FDA's CVM update. FDA reviewed more than 95 cases. Nearly 100 horses developed serious joint infections, and at least 20 were humanely euthanized after treatment failed. Those are only the deaths reported to FDA.

Neogen's letter redacts the manufacturer's name, but FDA's update names both recipients, and the letter to Sciarra Aeromed of Carmel, New York, lists the same five fungi. Its February inspection found a cleanroom built inside unclassified warehouse space, no sporicidal cleaning agent, no viable air or glove sampling during production, no smoke studies, and gowning that left faces and ankles exposed. Photos show ceiling leaks and a warehouse door with gaps big enough for pests.

The gap is regulatory as much as microbial. Neogen marketed HYCOAT as an animal device, and animal devices do not go through FDA premarket review. FDA says Neogen "did not proactively report adverse events," so the agency learned of the problem only when veterinarians called.

Two lessons. If you sell a product under your label that someone else makes, FDA holds you responsible: Neogen's letter says so in plain words, and cites its failure to oversee the contract site. And if vets routinely use your product off-label, FDA will ask why your label says nothing about it.

Key developments

FDA wants a new rule for vape and pouch applications

On September 28 FDA announced it intends to evaluate changes to the premarket tobacco product application (PMTA) framework, "including through initiation of new rulemaking to replace the current framework." It cited its experience with the 2021 rule, a lawsuit in the Northern District of Texas, "the widespread development of an illicit and unregulated market," and the pace of new products. There is no proposal and no timeline. FDA says it will keep reviewing PMTAs under the current statutory standard, so for anyone with a pending application, nothing changes today. Retail enforcement continued the same week: sfshoply.com got a warning letter for selling an Adalya disposable vape to a buyer under 21.

Endotoxin in famotidine, lab records in the shred bin

The Fresenius Kabi letter covers its Melrose Park, Illinois, sterile injectables plant. Patients had apparent pyrogenic reactions after famotidine for injection. The plant had released batches despite bioburden action-limit failures because finished-product tests passed, and retained samples later failed endotoxin testing. Three batches were recalled. At Curia's API plant in Rensselaer, New York, analysts ran thousands of unexplained chromatography injections over 30 months, and an investigator found original lab printouts in shred bins. Kellin Chemicals in China refused a preannounced inspection, which alone makes its APIs adulterated.

Contract-made acne and OTC products

Bentley Laboratories' letter says Geologie Acne Control Body Wash and Perricone MD Acne Relief Maximum Strength Spot Gel are unapproved new drugs. The acne monograph (M006) doesn't permit glycolic acid, lactic and succinic acids, citrulline, or tea tree oil as actives, and the labels' claims for those ingredients made them actives in FDA's eyes. Stream2Sea in Florida, VeganicSKN in Australia, and Babikian Healthcare Products in Armenia were cited for skipping identity testing of incoming components, finished-product testing, or both. If a contract lab makes your OTC product, monograph conformity and release testing are still your problem.

Compounded glutathione and counterfeit Ozempic

Greenwich Rx, a 503A pharmacy in Tomball, Texas, recalled ten lots of glutathione 200 mg/mL for elevated endotoxin. Two patients needed emergency care after IV doses of a product meant for subcutaneous use. Federal prosecutors also charged two Indian nationals with smuggling counterfeit Ozempic from China, allegedly continuing after FDA's December 2023 warning.

Raw milk cheese, Listeria, and wheat in sugar

Sierra Nevada Cheese Company recalled all Graziers raw milk cheese after FDA and CDC tied 13 E. coli O26:H11 illnesses to its medium cheddar; no lot has been identified. Middlefield Original Cheese Cooperative in Ohio got a warning letter after Listeria turned up in its environment following a 2025 recall. United Sugar Producers & Refiners pulled powdered and light brown sugar, including Target's Good & Gather, over possible wheat kernels.

The bigger picture

CVM is usually the quietest center in the warning letter data. From 2024 through mid-2026 it posted between 2 and 8 letters a quarter. In the third quarter of 2026 it posted 13. Four went to dairy and livestock operations over drug residues or misuse (Allandale Dairy, Tex-Stein Dairy, DeJong Family Dairy, and Wilson Livestock). Three were CGMP letters to animal drug makers. Three went to animal food firms, including raw pet food makers Viva Raw and Raaw Energy. Then the two HYCOAT letters, and one to Epicur Pharma, which marketed compounded omeprazole and buprenorphine injections with claims comparing them to approved drugs.

Our reading is that animal health is getting more enforcement attention than at any point since 2024, and the letters reach past livestock residues to pet food, contract manufacturing, and compounding. If you sell into veterinary channels, a CVM warning letter is no longer a remote risk.

CVM warning letters posted by quarter, Q1 2024 to Q3 2026
CVM warning letters posted by quarter, Q1 2024 to Q3 2026

What to watch

  • Neogen and Sciarra responses are due 15 working days after receipt. Sciarra told FDA it will fix the facility before restarting production.
  • International mail. A new guidance delays enforcement of the prior notice requirement to submit mail tracking numbers for food until May 1, 2027.
  • Frozen berries, again. Frutas y Hortalizas del Sur expanded its E. coli O145:H28 recall to more Great Value lots sold at Walmart in 30 states and one Trader Joe's lot.
  • Sprout seeds. EAK Distribution recalled broccoli sprouting seeds sold on Amazon after FDA found Salmonella in a seed lot tied to a sprout grower in a multistate outbreak.
  • Infant breathing hoses. Draeger's VentStar Resus Neo hoses can crack and detach. FDA made it Class I; no injuries had been reported as of September 3.

Policy Canary tracks every FDA action, warning letters, recalls, guidance, and rules, against the specific products you make, by name and by ingredient. See what we would flag for your products.

Get this in your inbox every Friday.

Free FDA intelligence digest. No account required.

Share this article

More in Weekly Roundup

What if this analysis was about YOUR products?

Policy Canary monitors the FDA for your specific products — by name, by ingredient, by facility. Start your free trial.

Start Free Trial